Have we forgotten the purpose of phase III studies?
- PMID: 17984184
- DOI: 10.1200/JCO.2007.13.7810
Have we forgotten the purpose of phase III studies?
Comment in
-
Hillmen trial of alemtuzumab in first-line chronic lymphocytic leukemia still provides valuable information.J Clin Oncol. 2008 May 10;26(14):2411-2; author reply 2412-3. doi: 10.1200/JCO.2008.16.3782. J Clin Oncol. 2008. PMID: 18467736 No abstract available.
Comment on
-
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.J Clin Oncol. 2007 Dec 10;25(35):5616-23. doi: 10.1200/JCO.2007.12.9098. Epub 2007 Nov 5. J Clin Oncol. 2007. PMID: 17984186 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
